APO Research
Talk to an analyst

APO RESEARCH · REPORT

Diagnostic Radiopharmaceuticals

Radiopharmaceuticals refer to a class of special medicines containing radionuclides for medical diagnosis and treatment. Compounds or biological preparations containing radionuclide labels used for medical diagnosis or treatment in the body. Diagnostic radiopharmaceuticals are radioisotopes that bind to biomolecules that can locate specific organs, tissues or cells in the body. These radiopharmaceuticals can be used to diagnose diseases.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Radiopharmaceuticals refer to a class of special medicines containing radionuclides for medical diagnosis and treatment. Compounds or biological preparations containing radionuclide labels used for medical diagnosis or treatment in the body. Diagnostic radiopharmaceuticals are radioisotopes that bind to biomolecules that can locate specific organs, tissues or cells in the body. These radiopharmaceuticals can be used to diagnose diseases.

Selected research

Market Structure

Global Diagnostic Radiopharmaceuticals Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

30 December 2025190 pages

Choose your research edition.

Industry ResearchDiagnostic Radiopharmaceuticals Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Diagnostic Radiopharmaceuticals Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Diagnostic Radiopharmaceuticals Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Diagnostic Radiopharmaceuticals Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Diagnostic Radiopharmaceuticals Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

Radiopharmaceuticals refer to a class of special medicines containing radionuclides for medical diagnosis and treatment. Compounds or biological preparations containing radionuclide labels used for medical diagnosis or treatment in the body. Diagnostic radiopharmaceuticals are radioisotopes that bind to biomolecules that can locate specific organs, tissues or cells in the body. These radiopharmaceuticals can be used to diagnose diseases.

North America is the world's major consumer region, with sales accounting for 41.59% of the global total in 2019. Europe is also a major consumer region, accounting for 24.5% of the global market. China is also a very important consumer region due to the large number of cancers. At present, products represented by Cardinal Health, GE Healthcare, Curium Pharma, Jubilant Pharma, Bracco Imaging, etc. occupy a major position in the global market.

This report provides an overview of the global Diagnostic Radiopharmaceuticals market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Diagnostic Radiopharmaceuticals and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Diagnostic Radiopharmaceuticals sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Diagnostic Radiopharmaceuticals market size, projected growth trends, production technologies, key applications, and end-use industries.

Diagnostic Radiopharmaceuticals Segment by Company

Cardinal Health

GE Healthcare

Curium Pharma

Jubilant Pharma

Bracco Imaging

Advanced Accelerator Applications

SIEMENS

China Isotope & Radiation

Dongcheng Pharmaceutical Group

Lantheus

Eli Lilly

Diagnostic Radiopharmaceuticals Segment by Type

Technetium 99

Fluorine 18

Other

Diagnostic Radiopharmaceuticals Segment by Application

Oncology

Cardiology

Other

Diagnostic Radiopharmaceuticals Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diagnostic Radiopharmaceuticals market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Diagnostic Radiopharmaceuticals and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diagnostic Radiopharmaceuticals.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Diagnostic Radiopharmaceuticals market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Diagnostic Radiopharmaceuticals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Diagnostic Radiopharmaceuticals in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Diagnostic Radiopharmaceuticals in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Diagnostic Radiopharmaceuticals Industry Trends Table 2. Diagnostic Radiopharmaceuticals Industry Drivers Table 3. Diagnostic Radiopharmaceuticals Industry Opportunities and Challenges Table 4. Diagnostic Radiopharmaceuticals Industry Restraints Table 5. Global Diagnostic Radiopharmaceuticals Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Diagnostic Radiopharmaceuticals Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Diagnostic Radiopharmaceuticals Sales Market Share by Manufacturers Table 9. Global Diagnostic Radiopharmaceuticals Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Diagnostic Radiopharmaceuticals Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Diagnostic Radiopharmaceuticals Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Diagnostic Radiopharmaceuticals Manufacturers, Product Type & Application Table 13. Global Diagnostic Radiopharmaceuticals Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Diagnostic Radiopharmaceuticals by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Technetium 99 Table 17. Major Manufacturers of Fluorine 18 Table 18. Major Manufacturers of Other Table 19. Global Diagnostic Radiopharmaceuticals Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Diagnostic Radiopharmaceuticals Sales by Type (2021-2026) & (K Units) Table 21. Global Diagnostic Radiopharmaceuticals Sales by Type (2027-2032) & (K Units) Table 22. Global Diagnostic Radiopharmaceuticals Sales Market Share by Type (2021-2026) Table 23. Global Diagnostic Radiopharmaceuticals Sales Market Share by Type (2027-2032) Table 24. Global Diagnostic Radiopharmaceuticals Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Diagnostic Radiopharmaceuticals Revenue by Type (2021-2026) & (K Units) Table 26. Global Diagnostic Radiopharmaceuticals Revenue by Type (2027-2032) & (K Units) Table 27. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Type (2021-2026) Table 28. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Oncology Table 30. Major Manufacturers of Cardiology Table 31. Major Manufacturers of Other Table 32. Global Diagnostic Radiopharmaceuticals Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Diagnostic Radiopharmaceuticals Sales by Application (2021-2026) & (K Units) Table 34. Global Diagnostic Radiopharmaceuticals Sales by Application (2027-2032) & (K Units) Table 35. Global Diagnostic Radiopharmaceuticals Sales Market Share by Application (2021-2026) Table 36. Global Diagnostic Radiopharmaceuticals Sales Market Share by Application (2027-2032) Table 37. Global Diagnostic Radiopharmaceuticals Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Diagnostic Radiopharmaceuticals Revenue by Application (2021-2026) & (K Units) Table 39. Global Diagnostic Radiopharmaceuticals Revenue by Application (2027-2032) & (K Units) Table 40. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Application (2021-2026) Table 41. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Application (2027-2032) Table 42. Global Diagnostic Radiopharmaceuticals Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Diagnostic Radiopharmaceuticals Sales by Region (2021-2026) & (K Units) Table 44. Global Diagnostic Radiopharmaceuticals Sales Market Share by Region (2021-2026) Table 45. Global Diagnostic Radiopharmaceuticals Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Diagnostic Radiopharmaceuticals Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Diagnostic Radiopharmaceuticals Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Diagnostic Radiopharmaceuticals Sales by Country (2021-2026) & (K Units) Table 49. North America Diagnostic Radiopharmaceuticals Sales by Country (2027-2032) & (K Units) Table 50. Europe Diagnostic Radiopharmaceuticals Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Diagnostic Radiopharmaceuticals Sales by Country (2021-2026) & (K Units) Table 52. Europe Diagnostic Radiopharmaceuticals Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Diagnostic Radiopharmaceuticals Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Diagnostic Radiopharmaceuticals Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Diagnostic Radiopharmaceuticals Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Diagnostic Radiopharmaceuticals Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Diagnostic Radiopharmaceuticals Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Diagnostic Radiopharmaceuticals Sales by Country (2027-2032) & (K Units) Table 59. Global Diagnostic Radiopharmaceuticals Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Diagnostic Radiopharmaceuticals Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Diagnostic Radiopharmaceuticals Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Region (2021-2026) Table 63. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Region (2027-2032) Table 64. Cardinal Health Company Information Table 65. Cardinal Health Business Overview Table 66. Cardinal Health Diagnostic Radiopharmaceuticals Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Cardinal Health Diagnostic Radiopharmaceuticals Product Portfolio Table 68. Cardinal Health Recent Development Table 69. GE Healthcare Company Information Table 70. GE Healthcare Business Overview Table 71. GE Healthcare Diagnostic Radiopharmaceuticals Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. GE Healthcare Diagnostic Radiopharmaceuticals Product Portfolio Table 73. GE Healthcare Recent Development Table 74. Curium Pharma Company Information Table 75. Curium Pharma Business Overview Table 76. Curium Pharma Diagnostic Radiopharmaceuticals Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Curium Pharma Diagnostic Radiopharmaceuticals Product Portfolio Table 78. Curium Pharma Recent Development Table 79. Jubilant Pharma Company Information Table 80. Jubilant Pharma Business Overview Table 81. Jubilant Pharma Diagnostic Radiopharmaceuticals Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Jubilant Pharma Diagnostic Radiopharmaceuticals Product Portfolio Table 83. Jubilant Pharma Recent Development Table 84. Bracco Imaging Company Information Table 85. Bracco Imaging Business Overview Table 86. Bracco Imaging Diagnostic Radiopharmaceuticals Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Bracco Imaging Diagnostic Radiopharmaceuticals Product Portfolio Table 88. Bracco Imaging Recent Development Table 89. Advanced Accelerator Applications Company Information Table 90. Advanced Accelerator Applications Business Overview Table 91. Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Product Portfolio Table 93. Advanced Accelerator Applications Recent Development Table 94. SIEMENS Company Information Table 95. SIEMENS Business Overview Table 96. SIEMENS Diagnostic Radiopharmaceuticals Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. SIEMENS Diagnostic Radiopharmaceuticals Product Portfolio Table 98. SIEMENS Recent Development Table 99. China Isotope & Radiation Company Information Table 100. China Isotope & Radiation Business Overview Table 101. China Isotope & Radiation Diagnostic Radiopharmaceuticals Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. China Isotope & Radiation Diagnostic Radiopharmaceuticals Product Portfolio Table 103. China Isotope & Radiation Recent Development Table 104. Dongcheng Pharmaceutical Group Company Information Table 105. Dongcheng Pharmaceutical Group Business Overview Table 106. Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Product Portfolio Table 108. Dongcheng Pharmaceutical Group Recent Development Table 109. Lantheus Company Information Table 110. Lantheus Business Overview Table 111. Lantheus Diagnostic Radiopharmaceuticals Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Lantheus Diagnostic Radiopharmaceuticals Product Portfolio Table 113. Lantheus Recent Development Table 114. Eli Lilly Company Information Table 115. Eli Lilly Business Overview Table 116. Eli Lilly Diagnostic Radiopharmaceuticals Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Eli Lilly Diagnostic Radiopharmaceuticals Product Portfolio Table 118. Eli Lilly Recent Development Table 119. Key Raw Materials Table 120. Raw Materials Key Suppliers Table 121. Diagnostic Radiopharmaceuticals Distributors List Table 122. Diagnostic Radiopharmaceuticals Customers List Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. Diagnostic Radiopharmaceuticals Product Image Figure 2. Global Diagnostic Radiopharmaceuticals Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Diagnostic Radiopharmaceuticals Market Size (2021-2032) & (US$ Million) Figure 4. Global Diagnostic Radiopharmaceuticals Sales (2021-2032) & (K Units) Figure 5. Global Diagnostic Radiopharmaceuticals Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Diagnostic Radiopharmaceuticals Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Technetium 99 Image Figure 9. Fluorine 18 Image Figure 10. Other Image Figure 11. Global Diagnostic Radiopharmaceuticals Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Diagnostic Radiopharmaceuticals Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Diagnostic Radiopharmaceuticals Sales Market Share by Type (2021-2032) Figure 14. Global Diagnostic Radiopharmaceuticals Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Diagnostic Radiopharmaceuticals Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Type (2021-2032) Figure 17. Oncology Image Figure 18. Cardiology Image Figure 19. Other Image Figure 20. Global Diagnostic Radiopharmaceuticals Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Diagnostic Radiopharmaceuticals Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Diagnostic Radiopharmaceuticals Sales Market Share by Application (2021-2032) Figure 23. Global Diagnostic Radiopharmaceuticals Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Diagnostic Radiopharmaceuticals Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Application (2021-2032) Figure 26. North America Diagnostic Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Diagnostic Radiopharmaceuticals Sales Market Share by Country (2021-2032) Figure 28. U.S. Diagnostic Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Diagnostic Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Diagnostic Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Diagnostic Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Diagnostic Radiopharmaceuticals Sales Market Share by Country (2021-2032) Figure 33. Germany Diagnostic Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Diagnostic Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Diagnostic Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Diagnostic Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Diagnostic Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Diagnostic Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Diagnostic Radiopharmaceuticals Sales Market Share by Country (2021-2032) Figure 40. China Diagnostic Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Diagnostic Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Diagnostic Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Diagnostic Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Diagnostic Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Diagnostic Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Diagnostic Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Diagnostic Radiopharmaceuticals Sales Market Share by Country (2021-2032) Figure 48. Brazil Diagnostic Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Diagnostic Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Diagnostic Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Diagnostic Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Diagnostic Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Diagnostic Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Diagnostic Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Diagnostic Radiopharmaceuticals Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Diagnostic Radiopharmaceuticals Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Diagnostic Radiopharmaceuticals Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Diagnostic Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Figure 59. North America Diagnostic Radiopharmaceuticals Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Diagnostic Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Figure 61. Europe Diagnostic Radiopharmaceuticals Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Diagnostic Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Diagnostic Radiopharmaceuticals Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Diagnostic Radiopharmaceuticals Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Diagnostic Radiopharmaceuticals Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Diagnostic Radiopharmaceuticals Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Diagnostic Radiopharmaceuticals Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Technetium 99
  • Fluorine 18
  • Other
Applications
  • Oncology
  • Cardiology
  • Other
Companies covered
  • Cardinal Health
  • GE Healthcare
  • Curium Pharma
  • Jubilant Pharma
  • Bracco Imaging
  • Advanced Accelerator Applications
  • SIEMENS
  • China Isotope & Radiation
  • Dongcheng Pharmaceutical Group
  • Lantheus
  • Eli Lilly

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Diagnostic Radiopharmaceuticals Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Diagnostic Radiopharmaceuticals Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Diagnostic Radiopharmaceuticals Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Diagnostic Radiopharmaceuticals Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Diagnostic Radiopharmaceuticals Market Dynamics
  1. 2.1 Diagnostic Radiopharmaceuticals Industry Trends
  2. 2.2 Diagnostic Radiopharmaceuticals Industry Drivers
  3. 2.3 Diagnostic Radiopharmaceuticals Industry Opportunities and Challenges
  4. 2.4 Diagnostic Radiopharmaceuticals Industry Restraints
3 Diagnostic Radiopharmaceuticals Market by Manufacturers
  1. 3.1 Global Diagnostic Radiopharmaceuticals Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Diagnostic Radiopharmaceuticals Sales by Manufacturers (2021-2026)
  3. 3.3 Global Diagnostic Radiopharmaceuticals Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Diagnostic Radiopharmaceuticals Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Diagnostic Radiopharmaceuticals Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Diagnostic Radiopharmaceuticals Manufacturers, Product Type & Application
  7. 3.7 Global Diagnostic Radiopharmaceuticals Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Diagnostic Radiopharmaceuticals Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Diagnostic Radiopharmaceuticals Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Diagnostic Radiopharmaceuticals Tier 1, Tier 2, and Tier 3
4 Diagnostic Radiopharmaceuticals Market by Type
  1. 4.1 Diagnostic Radiopharmaceuticals Type Introduction
  2. 4.1.1 Technetium 99
  3. 4.1.2 Fluorine 18
  4. 4.1.3 Other
  5. 4.2 Global Diagnostic Radiopharmaceuticals Sales by Type
  6. 4.2.1 Global Diagnostic Radiopharmaceuticals Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Diagnostic Radiopharmaceuticals Sales by Type (2021-2032)
  8. 4.2.3 Global Diagnostic Radiopharmaceuticals Sales Market Share by Type (2021-2032)
  9. 4.3 Global Diagnostic Radiopharmaceuticals Revenue by Type
  10. 4.3.1 Global Diagnostic Radiopharmaceuticals Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Diagnostic Radiopharmaceuticals Revenue by Type (2021-2032)
  12. 4.3.3 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Type (2021-2032)
5 Diagnostic Radiopharmaceuticals Market by Application
  1. 5.1 Diagnostic Radiopharmaceuticals Application Introduction
  2. 5.1.1 Oncology
  3. 5.1.2 Cardiology
  4. 5.1.3 Other
  5. 5.2 Global Diagnostic Radiopharmaceuticals Sales by Application
  6. 5.2.1 Global Diagnostic Radiopharmaceuticals Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Diagnostic Radiopharmaceuticals Sales by Application (2021-2032)
  8. 5.2.3 Global Diagnostic Radiopharmaceuticals Sales Market Share by Application (2021-2032)
  9. 5.3 Global Diagnostic Radiopharmaceuticals Revenue by Application
  10. 5.3.1 Global Diagnostic Radiopharmaceuticals Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Diagnostic Radiopharmaceuticals Revenue by Application (2021-2032)
  12. 5.3.3 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Application (2021-2032)
6 Global Diagnostic Radiopharmaceuticals Sales by Region
  1. 6.1 Global Diagnostic Radiopharmaceuticals Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Diagnostic Radiopharmaceuticals Sales by Region (2021-2032)
  3. 6.2.1 Global Diagnostic Radiopharmaceuticals Sales by Region (2021-2026)
  4. 6.2.2 Global Diagnostic Radiopharmaceuticals Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Diagnostic Radiopharmaceuticals Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Diagnostic Radiopharmaceuticals Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Diagnostic Radiopharmaceuticals Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Diagnostic Radiopharmaceuticals Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Diagnostic Radiopharmaceuticals Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Diagnostic Radiopharmaceuticals Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Diagnostic Radiopharmaceuticals Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Diagnostic Radiopharmaceuticals Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Diagnostic Radiopharmaceuticals Revenue by Region
  1. 7.1 Global Diagnostic Radiopharmaceuticals Revenue by Region
  2. 7.1.1 Global Diagnostic Radiopharmaceuticals Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Diagnostic Radiopharmaceuticals Revenue by Region (2021-2026)
  4. 7.1.3 Global Diagnostic Radiopharmaceuticals Revenue by Region (2027-2032)
  5. 7.1.4 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Diagnostic Radiopharmaceuticals Revenue (2021-2032)
  8. 7.2.2 North America Diagnostic Radiopharmaceuticals Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Diagnostic Radiopharmaceuticals Revenue (2021-2032)
  11. 7.3.2 Europe Diagnostic Radiopharmaceuticals Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Diagnostic Radiopharmaceuticals Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Diagnostic Radiopharmaceuticals Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Diagnostic Radiopharmaceuticals Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Diagnostic Radiopharmaceuticals Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Cardinal Health
  2. 8.1.1 Cardinal Health Company Information
  3. 8.1.2 Cardinal Health Business Overview
  4. 8.1.3 Cardinal Health Diagnostic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Cardinal Health Diagnostic Radiopharmaceuticals Product Portfolio
  6. 8.1.5 Cardinal Health Recent Developments
  7. 8.2 GE Healthcare
  8. 8.2.1 GE Healthcare Company Information
  9. 8.2.2 GE Healthcare Business Overview
  10. 8.2.3 GE Healthcare Diagnostic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 GE Healthcare Diagnostic Radiopharmaceuticals Product Portfolio
  12. 8.2.5 GE Healthcare Recent Developments
  13. 8.3 Curium Pharma
  14. 8.3.1 Curium Pharma Company Information
  15. 8.3.2 Curium Pharma Business Overview
  16. 8.3.3 Curium Pharma Diagnostic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Curium Pharma Diagnostic Radiopharmaceuticals Product Portfolio
  18. 8.3.5 Curium Pharma Recent Developments
  19. 8.4 Jubilant Pharma
  20. 8.4.1 Jubilant Pharma Company Information
  21. 8.4.2 Jubilant Pharma Business Overview
  22. 8.4.3 Jubilant Pharma Diagnostic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Jubilant Pharma Diagnostic Radiopharmaceuticals Product Portfolio
  24. 8.4.5 Jubilant Pharma Recent Developments
  25. 8.5 Bracco Imaging
  26. 8.5.1 Bracco Imaging Company Information
  27. 8.5.2 Bracco Imaging Business Overview
  28. 8.5.3 Bracco Imaging Diagnostic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Bracco Imaging Diagnostic Radiopharmaceuticals Product Portfolio
  30. 8.5.5 Bracco Imaging Recent Developments
  31. 8.6 Advanced Accelerator Applications
  32. 8.6.1 Advanced Accelerator Applications Company Information
  33. 8.6.2 Advanced Accelerator Applications Business Overview
  34. 8.6.3 Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Product Portfolio
  36. 8.6.5 Advanced Accelerator Applications Recent Developments
  37. 8.7 SIEMENS
  38. 8.7.1 SIEMENS Company Information
  39. 8.7.2 SIEMENS Business Overview
  40. 8.7.3 SIEMENS Diagnostic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 SIEMENS Diagnostic Radiopharmaceuticals Product Portfolio
  42. 8.7.5 SIEMENS Recent Developments
  43. 8.8 China Isotope & Radiation
  44. 8.8.1 China Isotope & Radiation Company Information
  45. 8.8.2 China Isotope & Radiation Business Overview
  46. 8.8.3 China Isotope & Radiation Diagnostic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 China Isotope & Radiation Diagnostic Radiopharmaceuticals Product Portfolio
  48. 8.8.5 China Isotope & Radiation Recent Developments
  49. 8.9 Dongcheng Pharmaceutical Group
  50. 8.9.1 Dongcheng Pharmaceutical Group Company Information
  51. 8.9.2 Dongcheng Pharmaceutical Group Business Overview
  52. 8.9.3 Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Product Portfolio
  54. 8.9.5 Dongcheng Pharmaceutical Group Recent Developments
  55. 8.10 Lantheus
  56. 8.10.1 Lantheus Company Information
  57. 8.10.2 Lantheus Business Overview
  58. 8.10.3 Lantheus Diagnostic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Lantheus Diagnostic Radiopharmaceuticals Product Portfolio
  60. 8.10.5 Lantheus Recent Developments
  61. 8.11 Eli Lilly
  62. 8.11.1 Eli Lilly Company Information
  63. 8.11.2 Eli Lilly Business Overview
  64. 8.11.3 Eli Lilly Diagnostic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Eli Lilly Diagnostic Radiopharmaceuticals Product Portfolio
  66. 8.11.5 Eli Lilly Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Diagnostic Radiopharmaceuticals Value Chain Analysis
  2. 9.1.1 Diagnostic Radiopharmaceuticals Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Diagnostic Radiopharmaceuticals Production Mode & Process
  6. 9.2 Diagnostic Radiopharmaceuticals Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Diagnostic Radiopharmaceuticals Distributors
  9. 9.2.3 Diagnostic Radiopharmaceuticals Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst